Finance

Beta
Lists
603235:SHA
Jiangxi Tianxin Pharmaceutical Co Ltd
CNÂ¥23.34
-1.14%
(-0.27) 1D
Jun 16, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603235...
Open
CNÂ¥23.86
High
CNÂ¥23.88
Low
CNÂ¥23.22
Mkt. cap
10.31B
Avg. vol.
446.34K
Volume
319.40K
P/E ratio
19.58
52-wk high
CNÂ¥30.02
52-wk low
CNÂ¥22.71
EPS
CNÂ¥1.19
No. of employees
3K
Open
CNÂ¥23.86
High
CNÂ¥23.88
Low
CNÂ¥23.22
Mkt. cap
10.31B
Avg. vol.
446.34K
Volume
319.40K
P/E ratio
19.58
52-wk high
CNÂ¥30.02
52-wk low
CNÂ¥22.71
EPS
CNÂ¥1.19
No. of employees
3K
News stories
From sources across the web
About Jiangxi Tianxin Pharmaceutical Co Ltd
CEO-
Employees2.89K
FoundedSep 24, 2004
Headquarters-
SectorPersonal care products
Websitetxpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
503.44M
508.60M
714.10M
639.76M
Cost of goods sold
288.89M
292.05M
477.79M
383.91M
Cost of revenue
288.89M
292.05M
477.79M
383.91M
Research and development expenses
21.74M
28.86M
29.20M
20.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53.31M
53.07M
67.69M
49.46M
Operating expense
89.25M
59.24M
136.56M
70.18M
Total operating expenses
378.15M
351.28M
614.35M
454.08M
Operating income
125.29M
157.31M
99.74M
185.67M
Other non operating income
5.35M
6.85M
-7.39M
-8.06M
EBT including unusual items
164.67M
127.06M
152.78M
176.75M
EBT excluding unusual items
143.04M
161.65M
99.71M
176.75M
Income tax expense
27.23M
22.77M
21.50M
29.74M
Effective tax rate
16.53%
17.92%
14.07%
16.83%
Other operating expenses
16.24M
-21.03M
36.49M
-664.38K
Net income
137.45M
104.29M
131.28M
147.00M
Net profit margin
27.30%
20.51%
18.38%
22.98%
Earnings per share
-
-
-
-
Interest and investment income
3.52M
11.84M
17.87M
9.07M
Interest expense
-150.41K
-5.32M
-
-9.94M
Net interest expenses
3.37M
6.52M
17.87M
-867.88K
Depreciation and amortization charges
-
-
-
-
EBITDA
168.74M
195.07M
146.26M
232.19M
Gain or loss from assets sale
-
-
505.17K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer